In response to multiple studies, including an individual patient data meta-analysis, demonstrating its comparable sensitivity and significantly higher specificity compared with symptom screening [15–17, 19, 20, 22], in 2021, the WHO recommended CRP for TB screening in PLHIV [23]. Here, CRP is linked to tuberculosis.